Delivery Order SPE2DB20D1100-SPE2DB24FD4T9
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,248.34 firm fixed-price contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of January 18, 2024 and was awarded on January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,881.67 delivery order contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,716.14, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,738.34 firm fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used in the treatment of diabetes. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,728.00 firm fixed price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,546.47 firm fixed-price contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,148.35 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to manage diabetes. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,680.29, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of November 26, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,454.28 firm fixed-price contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication, with a period of performance through October 2024. This delivery order is part of a larger $999,999,999 IDC held by Amerisourcebergen to provide a...
This is a $16,287.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. The award has an ultimate completion date of March 31, 2025 and was issued on March 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...